Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country United States Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity Program Fulbright U.S. Scholar Program Program Country France Grant Activity Type Research Discipline Medical Sciences Specialization Biomedical Sciences Academic Year 2018-2019 Dates September 2018 - May 2019 Flex No Scholar type U.S. Scholar Award Title 8180-FR | Hauts-de-France Regional Award (Junior Research) Project Title Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity Scholar Information Grantee Patrick Lang Title Student Institution University of North Carolina at Chapel Hill Department Department of Cell Biology and Physiology School School of Medicine Host Institutions Institution Institut Pasteur
Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity Program Fulbright U.S. Scholar Program Program Country France Grant Activity Type Research Discipline Medical Sciences Specialization Biomedical Sciences Academic Year 2018-2019 Dates September 2018 - May 2019 Flex No Scholar type U.S. Scholar Award Title 8180-FR | Hauts-de-France Regional Award (Junior Research) Project Title Targeting MET for the Treatment of Lung Cancer Patients with MET Exon 14 Mutation may be Associated with Improved Survival and Decreased Morbidity Scholar Information Grantee Patrick Lang Title Student Institution University of North Carolina at Chapel Hill Department Department of Cell Biology and Physiology School School of Medicine Host Institutions Institution Institut Pasteur